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Neurobiology of Disease
Loss of -III Spectrin Leads to Purkinje Cell Dysfunction
Recapitulating the Behavior and Neuropathology of
Spinocerebellar Ataxia Type 5 in Humans
EmmaM. Perkins,1 Yvonne L. Clarkson,1Nancy Sabatier,1David M. Longhurst,1 Christopher P. Millward,1
Jennifer Jack,1 Junko Toraiwa,1Mitsunori Watanabe,2 Jeffrey D. Rothstein,3 Alastair R. Lyndon,4David J. A. Wyllie,1
Mayank B. Dutia,1 andMandy Jackson1
1The Centre for Integrative Physiology, The University of Edinburgh, George Square, Edinburgh EH8 9XD, United Kingdom, 2Department of Neurology,
Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan, 3Department of Neurology and Neuroscience, Johns Hopkins University,
Baltimore, Maryland 21287, and 4School of Life Sciences, Heriot-Watt University, Riccarton, Edinburgh EH14 4AS, United Kingdom
Mutations in SPTBN2, the gene encoding -III spectrin, cause spinocerebellar ataxia type 5 in humans (SCA5), a neurodegenerative
disorder resulting in loss of motor coordination. How these mutations give rise to progressive ataxia and what the precise role -III
spectrin plays in normal cerebellar physiology are unknown. We developed a mouse lacking full-length -III spectrin and found that
homozygous mice reproduced features of SCA5 including gait abnormalities, tremor, deteriorating motor coordination, Purkinje cell
loss, and cerebellar atrophy (molecular layer thinning). In vivo analysis reveals an age-related reduction in simple spike firing rate in
surviving -III/ Purkinje cells, whereas in vitro studies show these neurons to have reduced spontaneous firing, smaller sodium
currents, and dysregulation of glutamatergic neurotransmission. Our data suggest an early loss of EAAT4- (protein interactor of -III
spectrin) and a subsequent loss of GLAST-mediated uptakemayplay a role in neuronal pathology. These findings implicate a loss of-III
spectrin function in SCA5 pathogenesis and indicate that there are at least two physiological effects of-III spectrin loss that underpin a
progressive loss of inhibitory cerebellar output, namely an intrinsic Purkinje cell membrane defect due to reduced sodium currents and
alterations in glutamate signaling.
Introduction
Dominant spinocerebellar ataxias (SCAs) are a heterogeneous
group of inherited neurodegenerative disorders characterized by
postural abnormalities, progressive motor incoordination, and
cerebellar degeneration (Duen˜as et al., 2006; Soong and Paulson,
2007). Recently, using a large kindred descended from the grand-
parents of President Abraham Lincoln, mutations in SPTBN2,
the gene encoding -III spectrin, were found to cause spinocer-
ebellar ataxia type 5 (Ikeda et al., 2006).However, themechanism
through which the in-frame deletions and missense mutations
cause disease is still unknown, with toxic gain-of-function, loss-
of-function with a dominant-negative effect on wild-type pro-
tein, or haploinsufficiency all being possibilities.
Spectrins, heterotetramers consisting of two  and two  sub-
units, are important structural components of the plasma mem-
brane skeleton and are thought to play a significant role in
restricting and stabilizing membrane-spanning proteins within
specific subdomains of the plasma membrane. -III spectrin is
primarily expressed in the nervous system with the highest levels
of expression in the cerebellum, where it is found in Purkinje cell
soma and dendrites (Sakaguchi et al., 1998; Jackson et al., 2001).
However, transcripts are also found in a number of different
organs (Stankewich et al., 1998), and low levels of -III spectrin
protein are detected in kidney and liver (our unpublished obser-
vation).We have shown that-III spectrin interacts with EAAT4,
the glutamate transporter predominately expressed in Purkinje
cells, and stabilizes it at the plasma membrane (Jackson et al.,
2001). This implicates -III spectrin in clearance of glutamate
from the synaptic cleft, and consequently both modulation of
glutamatergic neurotransmission and prevention of glutamate-
mediated neurotoxicity. Other investigators have shown -III
spectrin interacts with ARP1 and is found in a complex with
dynactin (Holleran et al., 2001). Since dynactin is the acces-
sory protein that mediates the association of dynein with cyto-
plasmic vesicles, another suggested function of -III spectrin
is to facilitate protein trafficking by linking the microtubule
motor to vesicle-bound cargo. An earlier study also suggested
that -III spectrin associates with Golgi and cytoplasmic vesicles
(Stankewich et al., 1998). In the case of Drosophila and Caeno-
rhabditis elegans, which have only one form of -spectrin, loss of
-spectrin results in destabilization of the neuromuscular junc-
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tion through loss of synaptic cell-adhesion molecules (Pielage
et al., 2005) and axonal breakage (Hammarlund et al., 2007),
respectively.
To further investigate the role of -III spectrin in normal
cerebellar development and SCA5 disease pathogenesis, we gen-
erated a mouse model in which -III spectrin expression is dis-
rupted. Here, we show that a functional -III spectrin knock-out
mouse (-III/) develops characteristic features of cerebellar
ataxia including progressivemotor incoordination, a wider hind-
limb gait, tremor, cerebellar atrophy, and Purkinje cell loss, thus
resembling clinical cases. Therefore, the -III/mouse is a new
model of cerebellar ataxia and, furthermore, our results implicate
several physiological defects arising from loss of -III spectrin in
disease pathogenesis.
Materials andMethods
Creation of -III spectrin-deficient mice. Mouse -III spectrin gene was
cloned from a 129Sv mouse BAC library (ResGen). To construct the
targeting vector, two gene fragments were subcloned into the vector
pPNT: a 2.0 kbKpnI fragment containing intron 6was cloned in between
the PGK-neo selection cassette and the PGK-tk cassette to form the 3
homology region; and a 7.0 kb XhoI-Sse I fragment containing exons 1
and 2was cloned upstream of the PGK-neo cassette forming the 5 region
of homology. The targeting vector was linearized with NotI and electro-
porated into 129/Ola embryonic stem (ES) cells (clone E14Tg2a). Stably
transfected ES cell clones were isolated after double selection with G418
and ganciclovir, and homologously recombined ES cell clones identified
by Southern blotting. Genomic DNA from 700 G418- and ganciclovir-
resistant ES clones was digested with SphI and transferred to Hybond-N
membrane (GE Healthcare). A 208 bp and a 160 bp intronic fragment,
external to vector, were used as 5 and 3 probes, respectively. Correctly
targeted ES clones were karyotyped and used for blastocyst injections.
The resulting chimeric males were bred with C57Bl6J females to identify
germ-line transmission by agouti coat color. Heterozygous F1 mice were
then backcrossed with C57Bl6J for at least six further generations. All
procedures involved in generation and analysis of mutant mice were
performed according to the United Kingdom Animals (Scientific Proce-
dures) Act (1986) and other Home Office regulations under specific
pathogen-free conditions.
Genotyping. Animals were genotyped by PCR analysis on genomic
DNA extracted from ear notch biopsies using ChargeSwitch gDNA tissue
kit (Invitrogen). A common upstream primer (5-gagcgagaagccgtgcagaag-
3) andprimers specific for thewild-type allele (5-aggatgatggtccacactagcc-3)
and the PGK-neo cassette in the mutant allele (5-ctaccggtggatgtggaatg-3)
were used for amplification. The 710 bp (from wild-type allele) and 562
bp (from targeted allele) PCR products were resolved by electrophoresis
on a 1% agarose gel. -III spectrin-deficient mice were fully viable and
generally born at a ratio consistent with Mendelian inheritance (1:2:1).
Litters composed of 41 wild-type (WT), 79 -III/, and 44 -III/
animals.
Immunoblotting.Whole cerebella were homogenized in 400 l of ice-
cold homogenization buffer [20 mM HEPES, pH 7.4, 1 mM EDTA, 1 mM
phenylmethylsulfonyl fluoride, and Protease Inhibitor Cocktail Set III
(Calbiochem)] with a Teflon-glass homogenizer. Protein concentrations
were determinedusingCoomassie-PlusReagent andbovine serumalbumin
as standard (Pierce). Protein samples were resolved by denaturing SDS-
PAGE and transferred to nitrocellulose membranes (GE Healthcare, Phar-
macia). Themembranes were blocked for 1 h at room temperature with 5%
w/v nonfat drymilk in Tris-buffered saline/Tween 20 (TBS/T) (20mMTris,
17 mMNaCl, pH 7.6, with 0.1% v/v Tween 20). Blots were incubated over-
night at 4°C with either rabbit anti-III spectrin, -EAAT4, -GLAST (1:200),
-GLT1 (1:4000), -GluR1 (1:1000; AbCam), or mouse anti-actin,
-calbindin (1:1600; Sigma) in blocking buffer. After washingwith TBS/T,
the blots were incubated for 1 h at room temperature with either HRP-
conjugated donkey anti-rabbit IgG, or HRP-conjugated sheep anti-
mouse IgG (1:4000; GE Healthcare, Pharmacia). Immunoreactive
proteins were visualized with ECL (Insight Biotechnology).
Immunohistochemistry. Brains were removed and immersion fixed
with 4% paraformaldehyde in 0.1 M sodium phosphate buffer, pH 7.4,
overnight at 4°C and cryoprotected by immersion in 0.1 M sodium phos-
phate buffer, pH 7.4, containing 30% sucrose. Tissue was quick-frozen
on dry ice, then 15-m-thick cerebellar sections were cut and fixed onto
microscope slides coated with poly-L-lysine. After air drying for 30 min,
sections either were stained for Nissl with cresyl violet (0.25%) or immu-
nostained. All quantification was performed in a blinded manner on
Nissl-stained sections by counting the number of Purkinje cells along a 1
mm linear length in folia II, III, IV, VI, andVIII (these folia were found to
be the most consistent in shape between animals) and the counts aver-
aged for each animal. The thickness of the molecular layer was measured
in each animal at the same three pointswithin each of the five chosen folia
and the 15 measurements averaged. For deep cerebellar nuclei (DCN)
counts, four areas (150 m2 each) were measured and the counts aver-
aged for each animal. For immunostaining, sections were incubated for
1 h with blocking solution (5% normal goat serum with 0.4% Triton
X-100 in PBS. Rabbit anti--III spectrin, anti-EAAT4 or mouse anti-
calbindin primary antibody (1:50) (2% normal goat serum/0.1% Triton
X-100 in PBS) was applied for 1 h at room temperature. Sections were
washed three times in PBS before applying goat anti-rabbit FITC-
conjugated secondary antibody (Cappel) or goat anti-mouse Cy-3-
conjugated secondary antibody (Jackson ImmunoResearch) for 1 h at
room temperature followed by three rinses in PBS and coverslippingwith
Vectashield (Vector Laboratories). Mouse anti-calbindin primary anti-
body (1:50) and anti-Neu-N antibody (1:100; Millipore Bioscience Re-
search Reagents) was applied overnight at 4°C and biotinylated
universal horse anti-mouse/rabbit IgG, diluted at 1:200 in PBS, was
applied for 1 h at room temperature. Detection of biotinylated sec-
ondary antibody was performed using ABC method with DAB and
H2O2 used as peroxidase substrate (Vector Laboratories). Images
were captured with an Olympus IX70 fluorescence microscope using
Openlab software (Improvision) or a Zeiss inverted LSM510 confocal
laser scanning microscope.
Electron microscopy. Brains were dissected out and immersion fixed
overnight (4°C) with a mixture of 2% paraformaldehyde and 2% glutar-
aldehyde in 0.1 M sodium cacodylate buffer, pH 7.3. Specimens were
postfixed in 1%osmium tetroxide in 0.1 M sodium cacodylate for 45min,
washed three times in 0.1 M sodium cacodylate buffer, and dehydrated in
50%, 70%, 90%, and 100% normal grade acetones for 10 min each,
followed by two 10min changes in analar acetone. Samples were embed-
ded in Araldite resin, and 1-m-thick sections cut, stainedwith toluidine
blue, and viewed in a light microscope to select suitable areas for inves-
tigation. Ultrathin 60-nm-thick sections were cut from selected areas,
stained with uranyl acetate and lead citrate, and viewed in a Phillips
CM120 transmission electron microscope (FEI). Morphological criteria
used were irregular cell body, dark cytoplasm, and shrinkage. Images
were taken on a Gatan Orius CCD camera.
Semiquantitative reverse transcriptase-PCR. Total RNA was extracted
from mouse cerebellum using RNeasy Mini kit (Qiagen), and reverse
transcriptase (RT)-PCRs were performed using One-Step RT-PCR kit
(Qiagen) according to manufacturer’s instructions. Primers for RT-
PCRs located in exon 1, 7, 34, and 36 of -III spectrin were: F1
5-atgagcagcactctgtcacccact-3; R7 5-gccaattcttttgccttccacagc-3; F34
5-ggcccagggaagtgtggcctt-3; and R36 5cttaaagaagctgaatcgtttttctgc-3.
Amplification of the ubiquitously expressed elongation factorwas used
to control for RNA levels (Stratagene).
Cell culture and transfection. -III spectrin cDNA lacking exons 2–6
was subcloned into the NotI site of pCDNA3.1 (Invitrogen) and a Myc-
tagged pRK5 vector. For microscopic observation, HEK293 and
Neuro2A cells were plated onto coverslips coatedwith poly-L-lysine in 35
mm dishes and transfected with 1 g of each DNA construct using Fu-
gene reagent (Roche) in accordance with the manufacturer’s instruc-
tions. Anti-c-myc (Ab-1; Calbiochem) and tetramethylrhodamine
isothiocyanate-conjugated goat anti-mouse IgG (SouthernBiotech) were
used for immunofluorescence. For cell homogenates and biotinylation
assays, HEK and HEK-rEAAT4 cells, respectively, were plated onto 35
mm dishes and transfected with 4 g of each DNA using Lipofectamine
2000 (Invitrogen) according to manufacturer’s instructions.
4858 • J. Neurosci., April 7, 2010 • 30(14):4857–4867 Perkins et al. •-III Spectrin-Deficient Mice Model SCA5
Motor coordination tests. Footprint patternswere analyzed using a run-
way (80 cm by 10.5 cm wide) with white paper at the bottom. Hindpaws
of animals were dipped in nontoxic, water-soluble black ink (Indian Ink,
Winsor & Newton). Three consecutive strides were measured for each
animal. Stride length measurements were taken from the base of two
consecutive paw prints on the same side, and the base width was mea-
sured as the distance between the center of one paw print to the center of
the next print on the opposite side. The elevated beam test was performed
using a narrow horizontal beam (2 cm wide, 80 cm long, held at a height
of 30 cm from the table). The number of hindpaw slips the animal made
while traversing the beam were counted. For the hanging wire test, mice
were placed on a wire cage lid, which was turned upside down, and the
latency to fall measured. A 60 s cutoff time was used. In the rotarod test,
the ability of mice to maintain balance on a stationary (maximum time,
60 s) or rotating (3, 5, and 10 rpm) 3-cm-diameter cylinder was assessed
(TSE Rotarod) and the time a mouse remained on the accelerating cyl-
inder recorded (maximum, 120 s).
Glutamate uptake assays. Each cerebellum was homogenized in 800l
of tissue buffer (5mMTris/320mM sucrose, pH 7.4) with Protease Inhib-
itor Cocktail Set III (Calbiochem), using Teflon-glass homogenizer. Each
samplewas split and pellets washed twice in ice-coldTissue Buffer, before
being resuspended in either Na-containing Krebs buffer (120 mM
NaCl, 25 mM NaHCO3, 5 mM KCl, 2 mM CaCl2, 1 mM KH2PO4, 1 mM
MgSO4, 10% glucose) or Na
-free Krebs (120 mM choline-Cl and 25
mM Tris-HCl, pH 7.4, substituted for NaCl and NaHCO3, respectively).
Samples were then incubatedwith 5M 3H-glutamate for 10min at 37°C
and uptake stopped by placing back on ice. Pellets were washed twice
with Wash Buffer (5 mM Tris/160 mM NaCl, pH 7.4) and radioactivity
measured using a scintillation counter. Na-dependent uptake was de-
termined by subtracting Na-free counts.
In vivo electrophysiology. Extracellular recordings were obtained from
Purkinje cells in the vermis of the posterior lobe (lobulesV andVI) inWT
and-III/mice anesthetized with intraperitoneal injection of 1.5 g/kg
urethane (solution at 12.5%). The head of the animal was immobilized in
a stereotaxic frame and the cerebellum exposed by a craniotomy extend-
ing from the obex to the lamboidal ridge. The dura was opened along the
midline, and the brain covered with amixture of paraffin oil and vaseline
to prevent dessication. Glass microelectrodes filled with 0.9%NaCl were
placed1mmon either side of themidline then lowered into the vermis
using a hydraulic micromanipulator (Narishige). Recordings of the
spontaneous firing activity were made to a depth of 2 mm. Purkinje cells
were identified by their characteristic firing of complex spikes followed
Figure1. Progressivemotor impairment in-III/mice.A,Westernblot analysis ofwhole cerebellar homogenates (10g) confirms full-length-III spectrin (270 kDa) is absent in-III/
mice, but a smallermolecularweight protein (250 kDa; arrowhead) is expressed at low levels in-III/ and-III/ animals. Degradation product is identified by an asterisk. Calbindin levels
confirm equal protein loading.B, Cerebellar sections, from3-week-oldmice, immunostainedwith anti--III spectrin and anti-calbindin antibody show intense-III labeling (arrow) ofWT (/)
dendritic tree but faint staining in-III/mice, although still present in proximal and distal dendrites. ML, Molecular layer; PCL, Purkinje cell layer. Scale bar, 50m. C, Left, Representative
footprints of 18-week-old WT and-III/ littermates. Base width shown by double arrow and stride length by solid line. Right, Summary data showing significant increase in-III/ base
width comparedwithWT at 18weeks ( p 0.0078), 6months ( p 2.82 106), and 1 year ( p 0.02) of age.D, Timemice remained on stationary rod before falling reveals 6-month-old and
1-year-old-III/mice are impaired ( p 0.004 and 0.0007). Mice were given four consecutive trials, withmaximum time of 60 s. E, Latency of 3-week-old animals to fall from rotarod at 3, 5,
and10 rpm.Miceweregiven four trials perdayandallowedamaximumretention timeof120 sper trial. Bothgenotypes improvedperformanceduring consecutivedaysat3and5 rpm,butdifference
in latency to fall remained significant in all comparisons, except on day 3 at 3 rpm (p 0.218). F, 6-month-old-III/mice failed to stay on rotarod at 3 rpm and showed no improvement.
G, Number of hindlimb slips-III/mice made when crossing narrow, elevated beam increased from 12 weeks of age ( p 0.001 and 0.0006). All data are means SEM (WT, N 5–12;
-III/, N 4–15). *p 0.05; **p 0.01; ***p 0.001.
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by a pause in simple spike firing (see Fig. 5).
Spike activity was digitized at 10 kHz for amin-
imum of 3 min for each cell of interest, using
Spike2 software (CED). The mean firing rates
of complex and simple spikes were quantified
using analysis functions in the Spike2 software.
Slice electrophysiology. Cerebella were dis-
sected out into ice-cold modified artificial CSF
(ACSF) containing the following (in mM): 60
NaCl, 118 sucrose, 26 NaHCO3, 2.5 KCl, 11
glucose, 1.3 MgCl2, and 1 NaH2PO4 at pH 7.4
when bubbled with 95% O2:5% CO2. The cer-
ebellar vermis was glued to the vibratome
cutting platform (Dosaka EM Co) with cyano-
acrylate adhesive. Two-hundred-micrometer-
thick sagittal slices were cut and incubated for
30 min at 30°C in standard ACSF composed of
the following (in mM): 119 NaCl, 2.5 CaCl2, 26
NaHCO3, 2.5 KCl, 11 glucose, 1.3MgCl2, and 1
NaH2PO4 at pH 7.4 when bubbled with 95%
O2:5% CO2. Slices were stored at room tem-
perature until required for recording. Slices
were transferred to a submerged recording
chamber and superfused with standard ACSF
(3–5 ml min1) at room temperature for
voltage-clamp experiments and at 32 2°C for
recording spontaneous action potentials. Pur-
kinje cells were visualizedwith 40 immersion
objective and Normarski differential interfer-
ence contrast optics. Whole-cell recordings
were obtained from Purkinje cells using thick-
walled borosilicate glass pipettes pulled to 5–8
M	. For recording action potentials, the inter-
nal solution contained the following (in mM):
125K-gluconate, 15KCl, 10HEPES, 5 EGTA, 2
MgCl2, 0.4 NaGTP, 2 NaATP, and 10 Na-
phosphocreatine, adjusted to pH 7.4 with
KOH. For parallel fiber (PF)-mediated EPSC
(PF-EPSC) measurements, the internal solu-
tion contained the following (in mM): 108
Cs-methanesulfonate, 9 NaCl, 9 HEPES, 1.8
EGTA, 1.8MgCl2, 0.4NaGTP, 2MgATP, 63 su-
crose, and 5 QX-314, adjusted to pH 7.4 with
CsOH. Picrotoxin (50 M) was added to the
ACSF. PF-EPSCs were evoked by placing a patch pipette filled with stan-
dard ACSF at the same position in the molecular layer and applying a
range of stimuli (1.5–5.0 V, 200s duration). Pairs of PF-EPSCs (100ms
apart) were evoked at 0.033 Hz, and aminimum of three PF-EPSCs were
averaged under each condition. Series resistances were 15 M	 and
were compensated for by 40–60%. Membrane currents and voltages
were filtered at 5 kHz and sampled at 10 and 200 kHz, respectively, for
voltage-clamp and current-clamp experiments. Data were acquired us-
ing pClamp 9 (Molecular Devices) and analyzed using IGOR Pro (Wave-
metrics). The amplitudes and decay time constants of PF-evoked EPSCs
were measured using the ChanneLab analysis program (Synaptosoft Inc).
Dissociated Purkinje cell electrophysiology. Purkinje cells were isolated
fromP16–P20mice using dissociation techniquesmodified fromRaman
and Bean (1997). Isolated Purkinje cells were visually identified by their
large, pear-shaped soma (due to the stump of the apical dendrite). The
control extracellular recording solution contained the following (inmM):
110 TEA-Cl, 25 NaCl, 2 BaCl2, 0.3 CdCl2, 10 HEPES, and 10 glucose,
buffered to pH 7.4 with NaOH. Recordings were made at room temper-
ature with borosilicate pipettes (3–5 M	) containing the following (in
mM): 117 CsCl, 9 EGTA, 9 HEPES, 1.8MgCl2, 14 Na-phosphocreatine, 4
MgATP, and 0.3 NaGTP, adjusted to pH 7.4 with CsOH. To isolate the
TTX-sensitive Na current voltage protocols were repeated in the pres-
ence of 300 nM TTX and subtracted from the control recordings.
Statistics. Statistical analysis was performed using Student’s t test, two
samples assuming unequal variance, apart from densitometry analysis of
Western blots where one sample t test was used with a predicted value of
100% forWTand proportion datawere arcsine transformed before t test.
Results
Generation of-III spectrin-deficient mice
Weused targeted recombination to knock out expression of-III
spectrin, and our targeting strategy involved replacing exons 3–6
with the neomycin-resistance gene (see Materials and Methods).
In the recombinant allele, when exon 2 is spliced onto exon 7 this
will disrupt the open reading frame, introducing a premature
stop codon at the beginning of exon 7. WT (/), heterozygous
(-III/;/), and homozygous (-III/;/) progeny
were identified by PCR analysis (see Materials and Methods).
To determine whether we had successfully abolished -III
spectrin expression, we analyzed, using a previously character-
ized polyclonal antibody raised against a C-terminal epitope of
-III spectrin (Jackson et al., 2001), whole cerebellar homoge-
nates byWestern blot analysis. This revealed that full-length-III
spectrin (270 kDa) was absent in -III/mice and its quantity
approximately halved (58.4 7.4% of WT) in -III/ animals
(Fig. 1A). However, a smaller molecular weight protein was de-
tected, at low levels, in -III/mice (18.8 2.2% of full-length
-III spectrin in WT) (Fig. 1A) and -III/ mice but not WT
Figure 2. Cerebellar degeneration in old-III/ spectrin mice. A, Cerebellar sections immunostained with anti-calbindin D
antibody reveal some ectopically expressed Purkinje cells (arrow) in 3-week-old-III/mice and shrunken Purkinje cell soma
in 6-month-old and 1-year-old-III/mice. ML, Molecular layer; GCL, granule cell layer; PCL, Purkinje cell layer. Scale bar, 50
m. B, Mean Purkinje cell density measured from cerebellar folia II-IV, VI, and VIII shows Purkinje cell loss in 6-month-old and
1-year-old but not 3-week-old -III/ mice. C, Mean molecular layer thickness shows thinning of molecular layer in old
-III/mice. All data are means SEM. *p 0.05; **p 0.01; ***p 0.001.
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animals. Confocal immunofluorescence microscopy revealed
that this protein was still located throughout the -III/ Pur-
kinje cell dendritic tree but, consistent with results fromWestern
blot analysis, at a substantially reduced level when comparedwith
WT -III spectrin (Fig. 1B).
We determined that the smaller molecular weight protein
arises from exon 1, not exon 2, being spliced onto exon 7 in the
targeted but not WT allele (supplemental Fig. 1A, available at
www.jneurosci.org as supplemental material). This retains the
reading frame, and so no premature stop codon is introduced.
Therefore, the mutant mice lack full-length -III spectrin but
express, at a low level, a form of -III spectrin (250 kDa) that
lacks most of the actin-binding domain encoded by exons 2–6
(supplemental Fig. 1B, available at www.jneurosci.org as supple-
mental material). In vitro studies demonstrate that
2-6III pro-
tein has no obvious gain-of-function or adverse property but, if
anything, appears to be less functional than WT (supplemental
Fig. 1C–F, available at www.jneurosci.org as supplemental mate-
rial), providing persuasive evidence that the -III/mouse is a
functional knock-out (hypomorph).
-III spectrin deficiency causes cerebellar ataxia
To test whether -III/mice show signs of ataxia, we first ana-
lyzed the footprint patterns of 6-week-old to 1-year-old animals
for differences in base width and stride
length (Fig. 1C). Hindlimb gait of -III/
mice became progressively wider than
that of littermate WT mice, but there was
no significant alteration in step length at
any age. However, variation in walking
speed down the runway introduced heter-
ogeneity in stride length that may have
masked genotype-dependent differences.
To quantify motor performance and
coordination, we used three behavioral
tests: stationary rod, rotarod, and elevated
beam. We found no significant difference
at 3 weeks of age between -III/ and
WTmice in maintaining balance on a sta-
tionary rod, whereas 6-month-old and
1-year-old -III/ mice struggled to
maintain balance (Fig. 1D). Performance
of young -III/mice on a rotating rod
(3 rpm) was initially significantly below
that of WT animals (Fig. 1E). However,
the performance improved on days 3 and
4, demonstrating that -III/ mice are
able to learnmotor tasks and can perform
well when the task is relatively easy.When
the speed was increased to 5 rpm, again
-III/ mice fell off more rapidly than
WT controls, and at 10 rpm they showed
no improvement during consecutive days
of testing (Fig. 1E). In contrast, by 6
months of age -III/ mice performed
muchworse and showedno improvement
even at 3 rpm (Fig. 1F; see supplemental
video, available at www.jneurosci.org as
supplemental material). To test whether
weakness contributed to poorer rotarod
performance, we evaluated muscle strength
with a hanging wire test. There was no sig-
nificant difference between the perfor-
mance of -III/ mice and WT animals at any age, suggesting
no muscle weakness (supplemental Fig. 2A, available at www.
jneurosci.org as supplemental material). Defects in motor per-
formance were also not due to body size variation as there was no
significant difference in body weight (supplemental Fig. 2B,
available at www.jneurosci.org as supplemental material). Fi-
nally, an elevated beam test was used to evaluate motor coordi-
nation and balance. The beam width was 2 cm, so that impaired
coordination and balance would result in hindlimb errors. The
-III/ mice were generally more hesitant to cross the beam
compared withWT animals (see supplemental video, available at
www.jneurosci.org as supplemental material) and when turning
sometimes fell off the beam, whichWTmice never did. Counting
the number of slips made by each animal while traversing the
beam showed that -III/mice made more, and generally big-
ger, slips than WT littermates from 12 weeks of age (Fig. 1G).
However,-III/mice remain ambulatory anddonot fall when
walking, resembling a mild form of ataxia that is observed in
SCA5 patients, in contrast to SCA1 transgenic mice, which dis-
play amore severe form of ataxia (Burright et al., 1995). Finally, a
tremor, a characteristic of some forms of cerebellar ataxia, was
observed in -III/ mice (see supplemental video, available at
www.jneurosci.org as supplemental material).
Figure 3. Signs of glutamate-mediated excitotoxicity in-III/ Purkinje cells. A1–B2, Ultrastructural analysis of cerebellar
sections from6-month-oldmice shows normal cell bodies inWT (A1,A2) but shrunken and electron dense soma in-III/ (B1,
B2).A1,B1, 170magnification; scale bar, 20m.A2,B2, 750magnification; scale bar, 5m.A3,B3, Electronmicrographs
(8400magnification; scale bars, 0.5m) show dilated smooth endoplasmic reticulum (ER) (B3, white arrowhead), and frag-
mented Golgi cisternae (arrow)with increased number of vesicles, some of which are invaginated (black arrowhead) in-III/
Purkinje cell somas compared with abundant rough ER (A3, white arrowhead) and normal Golgi apparatus (arrow) in WT. ML,
Molecular layer; GCL, granule cell layer; mt, mitochondria; all Purkinje cell bodies outlined. *Denotes from which cell high-
magnification images were obtained. Note different cell orientation in A2 and B2 compared with A1 and B1.
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Thinning of molecular layer and Purkinje cell loss in
-III/mice
We then looked for cerebellar atrophy and Purkinje cell loss, other
featuresofpatientswithataxia, in-III/mice. Stainingandquan-
tificationof cerebellar sections (seeMaterials andMethods) revealed
a thinning of themolecular layer, generally correlatedwith degener-
ationof dendrites (He et al., 2006), and aprogressive loss of Purkinje
cells at 6 months (WT, 50.4 3 cells/mm; -III/, 39 1.9 cells/
mm;N 4 and 3, respectively; p 0.035; andWT, 156.2 3m;
-III/, 112.2 3.1m; 73 2.5%ofWT; p 1.71 105) and
1 year of age (WT, 44.7 2.3 cells/mm; -III/, 26.9 1.5 cells/
mm;N 4; p 0.001; andWT, 150 8.5m; -III/, 109.3
4.7m;73 3.1%ofWT;p 0.005). This is not observed in young
(3-week-old) -III/ animals (WT, 51 3.4 cells/mm; -III/,
50.6  3.8 cells/mm; N  10 and 9, respectively; p  0.94; and
WT, 157.5 6.4m; -III/, 144.1 3.4m; p 0.097) (Fig.
2). There was no obvious variation in the pathology of the
lobules examined, with the same degree of neuronal loss and
atrophy being detected in all five examined. Immunostaining
also highlighted that the remaining Purkinje cell somas in old
-III/ animals were generally smaller (WT, 14.5  0.13 m;
-III/, 11.6 0.27 m; N 3, n 100/animal; p 0.0025)
and more irregularly shaped compared with WT littermates. It
also revealed that in young -III/ mice more Purkinje cells
were found to lie outside the Purkinje cell layer (WT, 0.28 
0.17%; -III/ 3  0.34%, N  3, n  350–520/animal; p 
0.006) (Fig. 2A), a finding also observed in SCA1 mutant mice
(Burright et al., 1995), whereas, we saw no differences in the
densities of DCN among genotypes at any age (supplemental Fig.
3, available at www.jneurosci.org as supplemental material).
Also, no gross morphological change (cell layer thickness) or
neuronal loss was observed in hippocampus (CA1 or CA3), cor-
tex, or dentate gyrus (supplemental Table 1, available at www.
jneurosci.org as supplemental material).
Subsequent ultrastructural analysis using transmission
electronmicroscopy of Purkinje cells confirmed somal shrink-
age and revealed an age-dependent accumulation of cells un-
dergoing “dark cell degeneration” (Fig. 3), a process linked to
AMPA receptor-elicited delayed excitotoxicity (Garthwaite
and Garthwaite, 1991; Turmaine et al., 2000), in -III/mice.
In 8-month-old -III/ animals, the percentage of Purkinje
cells with normalmorphology, relative toWT,was 29 2.1%com-
pared with 94.5  1.9% at 8 weeks of age (8 weeks: N  4, n 
18–35/animal; 8 months: N  5, n  7–18/animal; ***p  7.2 
106). These cells showed irregular somalmorphology, increased
electron density, dilated cisternae of endoplasmic reticulum de-
nuded of ribosomes, and changes to Golgi apparatus (numerous
vesicles, some of which were invaginated, a sign of Golgi frag-
mentation (Siddhanta et al., 2003)).
Loss of glutamate transporter expression in -III/mice
We therefore examined levels of EAAT4, the Purkinje cell-
specific glutamate transporter, in -III/mice, since our previ-
ous work showed EAAT4 interacts with and is stabilized by -III
spectrin (Jackson et al., 2001). Moreover, dramatic changes in
EAAT4 distribution were seen in SCA5 autopsy tissue (Ikeda et
al., 2006). Even at 3weeks of age, a decrease in EAAT4proteinwas
obvious in -III/mice compared withWT littermate controls
(66.5 3.5% of WT; N 6 each; p 0.0002) (Fig. 4A). Values
were normalized to calbindin, a Purkinje cell-specific marker.
Figure4. Loss of neuronal and astroglial glutamate transporters in-III/mice.A, Top, RepresentativeWestern blots illustrating loss of EAAT4 protein in-III/mice from3weeks of age.
Loss of astroglial glutamate transporter GLAST observed in -III/ mice from 12 weeks of age. No loss of GLT1 seen at any age. Bottom, Densitometry data quantifying levels. EAAT4 levels
normalized with calbindin, a Purkinje cell-specific marker ( p 0.02 for all ages). GLAST and GLT1 normalized with actin. B, Cerebellar sections immunostained with anti-GFAP antibody show no
astrogliosis in 1-year-old-III/mice. C, Glutamate uptake assays on whole cerebellar homogenates show reduced uptake in-III/mice from 12 weeks of age. All data are means SEM
(N 3–6). *p 0.05; **p 0.01.
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Immunofluorescence microscopy reveals that in -III/ mice
the remaining EAAT4 is still located throughout the dendritic
tree (supplemental Fig. 4, available at www.jneurosci.org as sup-
plemental material). In contrast, no loss of the astroglial gluta-
mate transporters GLAST (103.2 7.4% of WT; p 0.687) and
GLT1 (102.7 5.1% of WT; p 0.62) was observed at this early
stage.
Western blot analysis and densitometry (Fig. 4A) did reveal a
progressive reduction in GLAST protein compared with litter-
mate controls in 12-week-, 6-month-, and 1-year-old animals
(81.5  5.5% of WT, p  0.0206; 64  5% of WT, p  0.0055;
44.3 13% ofWT; p 0.05;N 3 each) in addition to the fairly
consistent loss of EAAT4 (67.3 6.2%ofWT, p 0.0033; 50.5
5.9%ofWT, p 0.0035; 62 5.5%ofWT, p 0.02). In contrast,
no reduction in GLT1 levels was observed at any age (108.3 
2.4%; 95.8 2.4%; 111.7 16.9%, respectively). The fact there
was no difference in GFAP expression in old -III/ animals
(Fig. 4B) suggests that the progressive loss of GLAST was not a
consequence of global defects in Bergmann glial integrity.
To investigate whether a loss of transporter protein corre-
sponded to a loss in cerebellar glutamate uptake, we measured
uptake of radioactively labeled glutamate into crude cerebellar
membrane preparations. We found a slight reduction in 12-
week-old-III/ animals (83.5 6.4%ofWT;N 3 and 4; p
0.08) when the ataxic phenotype starts to become obvious, and
further losses in 6-month-old and 1-year-old animals when the
motor deficits aremore pronounced (70 7.6% ofWT, p 0.047,
and 49.2 9.7% of WT, p 0.034, respectively;N 3 each) (Fig.
4C). Together, these results suggest that impaired glutamate uptake,
resulting from loss of EAAT4 and GLAST, correlates with neuronal
degeneration and plays a role in disease progression.
Reduced in vivo Purkinje cell simple spike firing rate in
-III/mice
Purkinje neurons provide the sole output from the cerebellar
cortex, in the form of inhibitory inputs to the DCN, and so it is
their firing rate that encodes the timing signals essential for mo-
tor planning, execution, and coordination. They are one of a few
neuronal populations that fire regularly in the absence of synaptic
input, but integration of excitatory and inhibitory inputs modu-
lates their output (Ha¨usser and Clark, 1997). We therefore re-
corded the in vivo firing pattern of Purkinje cells in 12-week-old
and 8-month-old -III/ andWTmice (Fig. 5). We found that
the simple spike firing rate was much less at 8 months than 12
weeks in -III/ mice compared with WT animals, indicating
an age-related decrease in output from surviving Purkinje cells.
There was no difference in the firing rate of complex spikes, but
some Purkinje cells from 8-month-old animals appeared to fire
only complex spikes, with the number of such cells being greater
in -III/mice (WT, 1 of 9 cells; -III/, 5 of 15 cells). These
cells were not included in the calculation of themean simple spike
firing rate.
Reduced spontaneous activity in -III/mice
To identify a possible cellular basis for the impaired Purkinje cell
output in -III/mice, we first measured spontaneous activity
in vitro (Fig. 6A). We found an approximately twofold reduction
in cells from 3-week-old-III/ animals (18.3 2.6Hz;N 2,
n 7) compared withWT cells (43.4 3.5Hz;N 3, n 9; p
5.22 105). The difference in the firing rate was not abolished in
the presence of bicuculline, an inhibitor of GABAergic neuro-
transmission, demonstrating that the observed reduction is not
due to increased inhibition. There was also very little effect on
firing rate when excitatory inputs were blocked with NBQX, re-
vealing very little tonic excitatory input within the in vitro slice,
similar to published data (Ha¨usser and Clark, 1997). Therefore,
the observed reduction is due to an intrinsic membrane defect
(i.e., altered ion channel activity) in -III/ Purkinje cells.
There was no further reduction in firing frequency observed in
cells from 6-month-old -III/ animals (20.8 1.2 Hz;N 2,
n  16; p  0.432), suggesting that the intrinsic defect does not
underlie the progressive nature of the disease phenotype. No sig-
nificant difference in cell input resistance, indicating no
change in “leak” conductance, or zero current potential was
detected between the two genotypes in either 3-week-old (WT,
74  12 M	; -III/ 78  8 M	; and WT, 55  1 mV;
-III/,54 3 mV) or 6-month-old animals (WT, 78 6
M	; -III/, 76 6M	; andWT,56 0.3 mV; -III/,
57  0.8 mV).
It is known that voltage-gated potassium and sodium chan-
nels play important roles in sustaining the high-frequency tonic
firing in Purkinje cells (Raman and Bean, 1999; Sacco et al., 2006;
Zagha et al., 2008). There was no difference in action potential
properties from WT and -III/ Purkinje cells (half-width:
WT, 0.24 0.05ms; -III/, 0.23 0.009ms, p 0.287; peak:
WT, 10.9 1.6 mV; -III/, 11.9 2.1 mV, p 0.483; hyper-
polarization peak: WT,60.6 1.9 mV; -III/,60.3 0.9
mV, p  0.337; n  7–10 for all analyses), suggesting that the
intrinsic firing defect was not due to a potassium channel;
whereas,whenwerecordedwhole-cell sodiumcurrents fromacutely
Figure 5. Reduced in vivo simple spike firing rate in old -III/ mice compared with
young-III/mice. Top, Representative trace of in vivo Purkinje cell output from 8-month-
oldWT and-III/ animals. Complex spike (dashed box) enlarged on right of trace. Bottom,
Firing rates of 12-week-old and 8-month-old-III/mice expressed as percentage of wild-
type frequency showreduction in simplebutnot complex spikeswith age.All data aremeans
SEM (12 weeks: WT, N 3, n 11;-III/, N 3, n 12; 8 months: WT, N 3, n 8;
-III/, N 3, n 10; p 0.02).
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dissociated P16-20 Purkinje neurons, they
were found to be significantly smaller in
-III/ Purkinje cells compared withWT
cells (Fig. 6B). The current–voltage rela-
tionships were similar for both genotypes,
indicating no difference in voltage depen-
dence of channel activation, and there was
no difference in cell capacitance (WT,
10.1 0.5 pF; -III/, 10.0 0.4 pF; p
0.92), suggesting that the growth and mor-
phology of mutant Purkinje cells was the
same as wild-type Purkinje cells. In addi-
tion, the resurgent sodium current ampli-
tude,which is an important aspectof the fast
repetitive Purkinje cell firing, accelerating
depolarization between action potentials,
was also found to be smaller in -III/
cells (Fig. 6C). These results suggest that it is
a sodium channel defect that underlies the
changes in the intrinsic membrane proper-
ties of-III/ Purkinje cells and that-III
spectrin may play a role in maintaining a
high density of sodium channels within the
somaanddendrites, similar to-IVspectrin
in axons (Komada and Soriano, 2002).
Altered glutamatergic transmission in
-III/mice
Next, since the tonic simple spike firing
rate is increased by PF inputs, we exam-
ined, in cerebellar slices, PF-EPSCs. We
found that PF-EPSC amplitudes, at vari-
ous stimuli, were considerably larger in
6-week-old-III/mice compared with
WT (Fig. 7A,B). However, no enhance-
ment in PF-EPSC peak amplitude was
seen in cells from 6-month-old -III/
animals, and recordings from 1-year-old
-III/ animals reveal a decrease com-
pared with WT cells (Fig. 7A,B). This in-
dicates Purkinje cell excitation is initially
enhanced, whichwould partly offset some
of the intrinsic Purkinje cell defect, but
then progressively declines in -III/
mice, compounding such deficits.
Western blot analysis of cerebellar tis-
sue from these mice shows no difference
between genotypes in the level of GluR1,
anAMPA receptor subunit, to account for
the enhancement (97.7  1.8% of litter-
mate controls;N 3 and 4; p 0.3) (Fig.
7C). There is also no difference in paired-pulse facilitation be-
tween young -III/ and WT mice (1.25  0.14 and 1.25 
0.02, respectively; p  0.92) at 100 ms intervals, suggesting that a
difference in release probability does not underlie the larger EPSCs.
Instead, we found, similar to other published data (Takayasu et al.,
2004), that application of TBOA, a global glutamate transporter
antagonist, enhanced EPSC amplitude in young WT cells such
that there was no longer a significant difference in amplitude
between genotypes ( p  0.162). In contrast, a loss of AMPA
receptors (64.5  10% of WT; p  0.038) (Fig. 7C) and a slight
difference in paired-pulse facilitation (WT 1.4  0.03; -III/
1.29 0.03; p 0.02) is observed in 1-year-old-III/ animals.
Together, the results indicate that the decreased spontaneous
firing rate arising from loss of -III spectrin is, in young animals,
partly offset by greater excitation. However, this declines in older
animals, likely due to dendritic degeneration, and compounds
the intrinsic defect. Ultimately, the combination of Purkinje cell
death and reduced output from the surviving neurons leads to
less inhibition onto the DCN and a progressive ataxic phenotype.
Discussion
Loss of function in disease pathogenesis
In this study, we show that loss of -III spectrin produces a phe-
notype that resembles that of SCA5 patients with gait abnormal-
ities, progressive motor coordination deficits, thinning of the
Figure 6. Reduced spontaneous firing due to smaller sodium currents in Purkinje cells from-III/mice. A, Left, Represen-
tative traces of Purkinje cell spontaneous firingmeasured from3-week-oldWT and-III/ littermates. Right, Quantification of
mean firing frequency shows a reduction in spike frequency in Purkinje cells from 3-week-old-III/mice compared withWT
mice. Presence of NBQX or bicuculline does not abolish genotype difference in firing rate. B, Left, Sodium current traces from
representative cells evokedwith a series of 50ms depolarizations from a holding potential of90mV to potentials ranging from
80 to 20mV in 10mV increments. Right, Current–voltage relationship shows reducedwhole-cell current in-III/mice.
C, Left, Representative traces of resurgent sodium currents inWT and-III/mice. Currents evoked using a 20ms step to 30
mV, followed by repolarizations from –20 to –70 mV. Right, Mean peak resurgent sodium current versus voltage shows reduced
resurgent current in-III/mice. All data are means SEM. **p 0.01; ***p 0.001.
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molecular layer, and Purkinje cell loss (Stevanin et al., 1999; Bu¨rk
et al., 2004; Ikeda et al., 2006). Therefore, these results suggest that
loss of-III spectrin function underlies SCA5 pathogenesis, provid-
ing mechanistic insights into this autosomal-dominant disease. Al-
though autosomal-dominant diseases were originally thought to
result from toxic gain-of-function properties, recently several stud-
ies have implicated loss-of-function in the pathogenesis of other
dominant neurodegenerative diseases (VanRaamsdonk et al., 2005;
Thomas et al., 2006; Lim et al., 2008).
To date, heterozygous animals have displayed no obvious
ataxic phenotype (our unpublished observation), arguing against
haploinsufficiency as a disease mechanism and pointing toward
the human mutations possessing dominant-negative effects on
wild-type -III spectrin function. Additional models in which
-III spectrin with a known SCA5 mutation is expressed should
address this issue.
Sodium channel dysfunctionmay play a role in SCA5
Results from our in vitro current-clamp experiments revealed a
substantial reduction in spontaneous Purkinje neuron activity in
-III/mice. It is known that several ion channels are essential for
the sustained high-frequency tonic firing of Purkinje cells (Raman
and Bean, 1999; Sacco et al., 2006; Zagha et al., 2008). Moreover,
their loss in mice has been shown to cause ataxia (Sausbier et al.,
2004; Akemann and Knopfel, 2006; Levin et al., 2006; Walter et al.,
2006), and,more importantly, loss of ion channel function has been
identified as a genetic defect in several SCA subtypes (Browne et al.,
1994;Ophoff et al., 1996;Zhuchenkoetal., 1997;Waters et al., 2006).
Here, we report that there are reduced
sodium currents in acutely dissociated
Purkinje neurons from -III/mice. Of
note, a mutation in the gene that encodes
Nav1.6 has been found in a patient with
cerebellar atrophy and ataxia (Trudeau et
al., 2006), and IV-spectrin has been
shown to be required for correct localiza-
tion and stabilization of voltage-gated so-
dium and potassium channels within
axons and its loss results in progressive
ataxia (Parkinson et al., 2001; Komada
and Soriano, 2002). Together, these find-
ings suggest that sodium channel dys-
function is a factor in the pathogenesis of
some forms of SCA.
Spectrin is known to be a key factor in
forming specialized membrane domains
by linking transmembrane proteins such
as ion channels and cell-adhesion mole-
cules tomembrane phospholipids and the
actin cytoskeleton (Baines, 2009). Future
analysis of -III/ mice will delineate
the role -III spectrin plays in assembling
such domains as in its absence, or that of
associated proteins (Jenkins and Ben-
nett, 2001), sodium channels may no
longer be maintained within specific
subdomains, potentially contributing to
Purkinje cell dysfunction. Alternatively,
given -III spectrin’s putative role in fa-
cilitating protein transport (Holleran et
al., 2001) sodium channels may be in-
correctly trafficked.
Role for GLAST dysfunction in Purkinje cell degeneration
We found that in older -III/ mice, when motor deficits are
more pronounced, there is, in addition to the loss of EAAT4 seen
in young -III/ mice, a loss of the astroglial transporter
GLAST and corresponding reductions in glutamate uptake.
These results and the evidence of glutamate-mediated excitotox-
icity in Purkinje cells of -III/ mice from 6 months onward
suggest that it may be the delayed and progressive loss of GLAST
activity that leads to Purkinje cell degeneration and the worsen-
ing ataxic phenotype. Therefore, a non-cell-autonomous mech-
anism involving GLAST dysfunction might be a pathogenic
mechanism common to several SCAs. A complete loss-of-
function mutation in EAAT1 (GLAST), with a dominant-
negative effect on wild-type protein, was recently identified in a
child with episodic and progressive ataxia (Jen et al., 2005), and
this is in accordance with the finding that a GLAST knock-out
mouse possesses motor deficits (Watase et al., 1998). Further-
more, Purkinje cell degeneration is also seen when expanded
ataxin-7 is expressed solely in Bergmann glia, resulting in im-
paired glutamate uptake and loss of GLAST (Custer et al., 2006).
Therefore, glutamate-mediated excitotoxicity, involving GLAST
dysfunction, appears to play a critical role in Purkinje cell degen-
eration. Exactly how loss of -III spectrin gives rise to this is not
yet determined as -III spectrin does not appear to be expressed
in Bergmann glia (our unpublished observation). One possibility
is that -III spectrin, by orchestrating specialized microdomains
in Purkinje cells, assembles a multiprotein transmembrane com-
plex that maintains cell-to-cell contact with Bergmann glia and
Figure 7. Altered PF-EPSCs in -III/ mice. A, Left, Representative EPSC waveforms (4 V stimulus) from 6-week-old,
6-month-old, and 1-year-old WT and -III/ littermates. Right, Mean PF-EPSC amplitudes versus stimulus intensity shows
consistent differences betweenWTand-III/ cells at different stimuli.B,Meanpeak amplitude of EPSCs at 4 V stimulus shows
changes in PF-evoked currents with age in-III/ cells (6 weeks: N 3, n 10, p 0.001; 6 months: WT, N 2, n 10;
-III/,N2,n9,p0.44; 1 year:WT,N1,n6;-III/,N2,n11,p0.05).C,Westernblot analysis shows
loss of GluR1 in 1-year-old but no change in 6-week-old-III/mice.
Perkins et al. •-III Spectrin-Deficient Mice Model SCA5 J. Neurosci., April 7, 2010 • 30(14):4857–4867 • 4865
retains GLAST at the glial membrane. Alternatively, given the
role of spectrin in vesicular transport, itmay be that-III spectrin
is involved in the trafficking and secretion of trophic factors from
Purkinje cells that modulate GLAST protein levels.
Cumulative effects of different insults important for
disease progression
It is known that enhanced DCN hyperexcitability is sufficient to
induce ataxia (Shakkottai et al., 2004), and so any reduction in
GABAergic Purkinje cell output will contribute to motor deficits
by reducing inhibition onto the DCN. However, although we
identified a reduction in Purkinje cell intrinsic spontaneous fir-
ing rate in -III/ mice, this loss in output could not account
for the increasing disease severity as the same degree of reduction
was seen in 3-week-old and 6-month-old animals, which show
mild and more severe motor deficits, respectively.
Therefore, it is apparent that additional factors are involved in
modifying Purkinje cell output and affecting disease severity.
Furthermore, these findings highlight the cellular complexity of
cerebellar degeneration and ataxia. From the present study one
contributing factor would appear to be altered excitatory inputs.
Although previous work suggests EAAT4 to affect current decay
(Takayasu et al., 2005), our results show that in young -III/
mice, loss of EAAT4, and not GLAST (Fig. 4A) corresponds with
increased EPSCs (Fig. 7A,B). One possibility for the discrepancy
is that there is less compensation from the other transporter sub-
types in-III/mice comparedwith EAAT4 knock-outmice. It
may also be that GLAST is not in close opposition with dendritic
spines, reducing rapid removal of glutamate. In contrast, pro-
longedEPSCs in 1-year-old-III/ animals correlatewith a loss
of GLAST protein, similar to published data (Marcaggi et al.,
2003; Stoffel et al., 2004; Takayasu et al., 2005; Takatsuru et al.,
2006). These recordings also confirm that the removal of synap-
tically released glutamate is retarded in old -III/ mice and
raises the possibility that accumulation of glutamate results in
AMPA receptor desensitization. Unexpectedly, given the loss of
EAAT4, PF-EPSCs appear to decay faster in cells from young
-III/mice. Although both astroglial transporters are slightly
elevated in young -III/ mice this is unlikely to be the sole
reason for the faster decay, due to the small extent of protein
increase and lack of increased glutamate uptake. Previous work
has shown the sodium channel inhibitor QX-314 may not block
all channel subtypes equally (Yeh, 1978).We saw no difference in
decay constants between young WT and -III/ mice when
recordings were performed in the absence of sodium channel
blockers. It is possible, therefore, that in-III/mice, due to the
loss of sodium currents (Fig. 6B,C) there may be less of a con-
taminating current, precluding detection of slowing of the EPSC
decay. A similar finding of briefer PF-EPSC decay times was ob-
served in Nav1.6 knock-out animals (Levin et al., 2006).
Therefore, loss of EAAT4 may coincidentally have a biphasic
effect on Purkinje cell physiology: initially, the loss is compensa-
tory, maintaining Purkinje cell output and downstream DCN
inhibition, resulting in only a mild ataxic phenotype. However,
with time it elicits AMPA receptor-elicited excitotoxicity, resulting
in dendritic degeneration and eventual cell death, both leading to
progressively less Purkinje cell output and hyperexcitability of
DCN. Although there are no reports that EAAT4 knock-outmice
develop ataxia, a downregulation of EAAT4 is seen before any
behavioral phenotype in two other models of ataxia, SCA1 trans-
genic mouse (Lin et al., 2000; Serra et al., 2004) and staggerer
(Gold et al., 2003). Together, the results from these three different
mouse ataxia models suggest that EAAT4 may indeed be a com-
mon factor in early disease pathogenesis. It appears that for nor-
mal glutamatergic neurotransmission a loss of EAAT4 is not
deleterious, as GLAST is able to fully compensate, but when
GLAST is lost (as here), the cumulative effect becomes patho-
genic. A similar concerted role of EAAT4 and GLAST is apparent
in brain ischemia where Purkinje cells with low EAAT4 levels are
selectively lost in GLAST knock-out mice (Yamashita et al.,
2006).
In conclusion, the-III/mouse described here represents a
new model of cerebellar ataxia, showing not only progressive
behavioral abnormalities but also Purkinje cell degeneration.
This is similar to clinical cases, therefore making it a valuable
disease model for future study. The data also reveal that at least
two separate disease pathways are involved in the loss of inhibi-
tory cerebellar output underlying the ataxic phenotype. The first
is a decrease in the tonic firing rate of Purkinje cells due to altered
intrinsicmembrane properties arising from reduced sodium cur-
rents. The second is a reduction in excitatory inputs and Purkinje
cell death, possibly a consequence of glutamate-mediated excito-
toxicity, arising from loss of EAAT4- and GLAST-mediated glu-
tamate uptake. Therefore, -III spectrin appears to play an
important part in the prevention of glutamate-mediated neuro-
toxicity and to have a critical role in maintaining Purkinje cell
tonic firing. Future analysis of this model will provide a greater
understanding of what may be convergent disease mechanisms
for various SCAs (i.e., ion channel dysfunction, glutamate-
mediated excitotoxicity, and protein-trafficking defects). In-
sights into the human disease will be obtained by addressing
whether known SCA5mutations have similar detrimental effects
to the present mouse model on either or both of the sodium
channels or the astroglial glutamate transporter GLAST.
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